Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 3/2007

Content (12 Articles)

Review

CD4 regulatory T cells in human cancer pathogenesis

Keith L. Knutson, Mary L. Disis, Lupe G. Salazar

Original Article

The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2

Malcolm S. Mitchell, Teri A. Lund, Andrew K. Sewell, Francesco M. Marincola, Elyse Paul, Kim Schroder, Darcy B. Wilson, June Kan-Mitchell

Original Article

Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies

Rob C. Roovers, Toon Laeremans, Lieven Huang, Severine De Taeye, Arie J. Verkleij, Hilde Revets, Hans J. de Haard, Paul M. P. van Bergen en Henegouwen

Original Article

An altered peptide ligand for naïve cytotoxic T lymphocyte epitope of TRP-2(180–188) enhanced immunogenicity

Yan Tang, Zhihua Lin, Bing Ni, Jing Wei, Junfeng Han, Huiming Wang, Yuzhang Wu

Original Article

Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA

Koji Teramoto, Keiichi Kontani, Takuya Fujita, Yoshitomo Ozaki, Satoru Sawai, Noriaki Tezuka, Shozo Fujino, Yasushi Itoh, Osamu Taguchi, Reiji Kannagi, Kazumasa Ogasawara

Original Article

Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture

Klara Berencsi, Neal J. Meropol, John P. Hoffman, Elin Sigurdson, Lydia Giles, Pyapalli Rani, Rajasekharan Somasundaram, Tianqian Zhang, Jiri Kalabis, Laura Caputo, Emma Furth, Rolf Swoboda, Francesco Marincola, Dorothee Herlyn

Original Article

Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population

Penka N. Nikolova, Graham P. Pawelec, Snejina M. Mihailova, Milena I. Ivanova, Anastassia P. Myhailova, Daniela N. Baltadjieva, Daniela I. Marinova, Svetlomira S. Ivanova, Elissaveta J. Naumova

Original Article

Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy

Yuji Ueda, Tsuyoshi Itoh, Nobuaki Fuji, Sachio Harada, Hiroshi Fujiki, Keiji Shimizu, Atsushi Shiozaki, Arihiro Iwamoto, Takeshi Shimizu, Osam Mazda, Takafumi Kimura, Yoshiaki Sonoda, Masafumi Taniwaki, Hisakazu Yamagishi

Original Article

Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells

Il-Kang Na, Ulrich Keilholz, Anne Letsch, Sandra Bauer, Anne Marie Asemissen, Dirk Nagorsen, Eckhard Thiel, Carmen Scheibenbogen

Meeting Report

CIMT meets Strategies for Immune Therapy: Mainz, Germany, 04–05 May 2006

C. Gouttefangeas, C. M. Britten, E. Derhovanessian Badalians, G. Pawelec

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine